Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lew

Showing results (201-210 of 218) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|July 31, 1997
A controlled trial of an educational program to prevent low back injuriesL H Daltroy, M D Iversen, M G Larson, et al.
Journal of the American Academy of Dermatology|July 12, 2021
Comparison of two-year treatment adherence, persistence, discontinuation, reinitiation, and switching between psoriasis patients treated with ixekizumab or secukinumab in real-world settingsAndrew Blauvelt, Nianwen Shi, Najwa Somani, et al.
Dermatology and Therapy|October 15, 2021
Comparison of Real-World Treatment Patterns Among Biologic-Experienced Patients with Psoriasis Treated with Ixekizumab or Secukinumab Over 18 MonthsAndrew Blauvelt, Nianwen Shi, Russel Burge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2024
Choosing to End African American Health Disparities in Patients With Systemic Lupus ErythematosusMatthew H Liang, Edward R Lew, Patricia A Fraser, et al.
Brain Research|March 27, 1992
A cocaine analog and a GBR analog label the same protein in rat striatal membranesA Patel, J W Boja, J Lever, et al.
Journal of Medical Economics|May 26, 2022
Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settingsAndrew Blauvelt, Nianwen Shi, Mwangi J Murage, et al.
Medical Education|October 23, 2002
When enough is enough: a conceptual basis for fair and defensible practice performance assessmentL W T Schuwirth, L Southgate, G G Page, et al.
Journal of the American Academy of Dermatology|November 13, 2019
Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumabAndrew Blauvelt, Nianwen Shi, Russel Burge, et al.
Patient Preference and Adherence|March 27, 2020
Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or AdalimumabAndrew Blauvelt, Nianwen Shi, Russel Burge, et al.
Lupus|July 21, 1999
CD4 TCRBV CDR3 analysis in prevalent SLE cases from two ethnic groupsP A Fraser, L Y Lu, K DeCeulaer, et al.
Pageof 22

Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|July 31, 1997
A controlled trial of an educational program to prevent low back injuriesL H Daltroy, M D Iversen, M G Larson, et al.
Journal of the American Academy of Dermatology|July 12, 2021
Comparison of two-year treatment adherence, persistence, discontinuation, reinitiation, and switching between psoriasis patients treated with ixekizumab or secukinumab in real-world settingsAndrew Blauvelt, Nianwen Shi, Najwa Somani, et al.
Dermatology and Therapy|October 15, 2021
Comparison of Real-World Treatment Patterns Among Biologic-Experienced Patients with Psoriasis Treated with Ixekizumab or Secukinumab Over 18 MonthsAndrew Blauvelt, Nianwen Shi, Russel Burge, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 17, 2024
Choosing to End African American Health Disparities in Patients With Systemic Lupus ErythematosusMatthew H Liang, Edward R Lew, Patricia A Fraser, et al.
Brain Research|March 27, 1992
A cocaine analog and a GBR analog label the same protein in rat striatal membranesA Patel, J W Boja, J Lever, et al.
Journal of Medical Economics|May 26, 2022
Healthcare resource utilization and costs among patients with psoriasis treated with ixekizumab or adalimumab over 2 years of follow-up in real-world settingsAndrew Blauvelt, Nianwen Shi, Mwangi J Murage, et al.
Medical Education|October 23, 2002
When enough is enough: a conceptual basis for fair and defensible practice performance assessmentL W T Schuwirth, L Southgate, G G Page, et al.
Journal of the American Academy of Dermatology|November 13, 2019
Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumabAndrew Blauvelt, Nianwen Shi, Russel Burge, et al.
Patient Preference and Adherence|March 27, 2020
Comparison of Real-World Treatment Patterns Among Psoriasis Patients Treated with Ixekizumab or AdalimumabAndrew Blauvelt, Nianwen Shi, Russel Burge, et al.
Lupus|July 21, 1999
CD4 TCRBV CDR3 analysis in prevalent SLE cases from two ethnic groupsP A Fraser, L Y Lu, K DeCeulaer, et al.
Pageof 22